Perrigo Announces Approval For Over The Counter Children’s Cetirizine Oral Solution
Perrigo Company
(Nasdaq: PRGO; TASE) announced that it has received final approval
from the U.S. Food and Drug Administration to manufacture and market
over-the-counter (OTC) Children’s Cetirizine Hydrochloride Oral Solution
(Allergy) and Children’s Cetirizine Hydrochloride Oral Solution
(Hives-Relief), 1mg/mL.
The product will be marketed under store brand labels and is comparable
to McNeil Consumer Healthcare’s Children’s Zyrtec(R) (more…)